The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 33 results:
Author [ Title(Desc)] Type Year
Filters: Keyword is Pyrroles  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., Kostakis A., et al. (2012).  Adipokines: a novel link between adiposity and carotid plaque vulnerability.. Eur J Clin Invest. 42(12), 1278-86.
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., & Liapis C. D. (2010).  Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.. J Vasc Surg. 51(1), 114-21.
Athyros, V. G., Tziomalos K., Karagiannis A., Wierzbicki A. S., & Mikhailidis D. P. (2010).  Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?. Curr Opin Cardiol. 25(4), 406-10.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2014).  Are statins 'IDEAL' for non-alcoholic fatty liver disease?. Curr Med Res Opin. 30(2), 229-31.
Athyros, V. G., Karagiannis A., Ganotakis E. S., Paletas K., Nicolaou V., Bacharoudis G., et al. (2011).  Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.. Curr Med Res Opin. 27(8), 1659-68.
Kosmidou, M., Hatzitolios A. I., Molyva D., Raikos N., Savopoulos C., Daferera N., et al. (2009).  An association study between catalase -262C>T gene polymorphism, sodium-lithium countertransport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls.. Free Radic Res. 43(4), 385-9.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Tziomalos K., Skaperdas A., Pagourelias E., et al. (2007).  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.. Lipids. 42(11), 999-1009.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Atorvastatin: safety and tolerability.. Expert Opin Drug Saf. 9(4), 667-74.
B
Kadoglou, N. P. E., Gerasimidis T., Kapelouzou A., Moumtzouoglou A., Avgerinos E. D., Kakisis J. D., et al. (2010).  Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.. Eur J Vasc Endovasc Surg. 39(3), 258-65.
Katsiki, N., Athyros V. G., & Karagiannis A. (2014).  Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention.. Curr Med Res Opin. 30(1), 55.
C
Saratzis, A., Kitas G. D., Saratzis N., & Melas N. (2010).  Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.. Angiology. 61(2), 137-44.
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.. Curr Med Res Opin. 29(7), 791-2.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".. Dig Liver Dis. 45(1), 82-3.
Anagnostis, P., Selalmatzidou D., Polyzos S. A., Panagiotou A., Slavakis A., Panagiotidou A., et al. (2011).  Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.. Int J Clin Pract. 65(6), 679-83.
D
Bamias, A., Tzannis K., Beuselinck B., Oudard S., Escudier B., Diosynopoulos D., et al. (2013).  Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.. Br J Cancer. 109(2), 332-41.
E
Athyros, V. G., Mikhailidis D. P., Didangelos T. P., Giouleme O. I., Liberopoulos E. N., Karagiannis A., et al. (2006).  Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.. Curr Med Res Opin. 22(5), 873-83.
Athyros, V. G., Mikhailidis D. P., Liberopoulos E. N., Kakafika A. I., Karagiannis A., Papageorgiou A. A., et al. (2007).  Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with CHD and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.. Nephrol Dial Transplant. 22(1), 118-27.
Athyros, V. G., Tziomalos K., Kakafika A. I., Koumaras H., Karagiannis A., & Mikhailidis D. P. (2008).  Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.. Am J Cardiol. 101(4), 483-5.
Kanaki, A. I., Sarafidis P. A., Georgianos P. I., Kanavos K., Tziolas I. M., Zebekakis P. E., et al. (2013).  Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.. Am J Hypertens. 26(5), 608-16.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Paraskevas K. I., Tziomalos K., Anagnostis P., et al. (2008).  Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.. Curr Med Res Opin. 24(6), 1593-9.
Liontos, M., Trigka E-A., Korkolopoulou P., Tzannis K., Lainakis G., Koutsoukos K., et al. (2017).  Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.. World J Urol. 35(3), 411-419.
G
Goulas, A., Kosmidou M., Hatzitolios A. I., Molyva D., Fidani L., Giannopoulos S., et al. (2008).  Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients.. Basic Clin Pharmacol Toxicol. 102(6), 559-62.
I
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
L
Athyros, V. G., Elisaf M. S., Alexandrides T., Achimastos A., Ganotakis E., Bilianou E., et al. (2012).  Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.. Angiology. 63(5), 358-66.
Kanaki, A. I., Sarafidis P. A., Georgianos P. I., Stafylas P. C., Kanavos K., Tziolas I. M., et al. (2012).  Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.. J Hum Hypertens. 26(10), 577-84.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.